Acadia Healthcare (ACHC) Scheduled to Post Quarterly Earnings on Wednesday

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) will be releasing its earnings data after the market closes on Wednesday, May 1st. Analysts expect Acadia Healthcare to post earnings of $0.80 per share for the quarter. Investors that wish to listen to the company's conference call can do so using this link.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings results on Wednesday, February 28th. The company reported $0.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.05. The firm had revenue of $742.80 million during the quarter, compared to the consensus estimate of $727.60 million. Acadia Healthcare had a negative net margin of 0.74% and a positive return on equity of 11.21%. The company's revenue for the quarter was up 10.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.70 earnings per share. On average, analysts expect Acadia Healthcare to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Acadia Healthcare Trading Up 0.6 %

Shares of ACHC stock traded up $0.45 during trading hours on Wednesday, hitting $71.19. 454,423 shares of the company's stock traded hands, compared to its average volume of 560,294. The stock's 50 day simple moving average is $78.68 and its 200 day simple moving average is $77.72. The stock has a market cap of $6.58 billion, a PE ratio of -284.75, a price-to-earnings-growth ratio of 2.07 and a beta of 1.31. Acadia Healthcare has a 12 month low of $66.49 and a 12 month high of $87.77. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.48.

Insider Buying and Selling at Acadia Healthcare

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the business's stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the transaction, the director now directly owns 46,074 shares in the company, valued at $3,934,258.86. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 2.80% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on ACHC shares. Royal Bank of Canada reaffirmed an "outperform" rating and set a $94.00 price target on shares of Acadia Healthcare in a research note on Monday, March 4th. TheStreet raised shares of Acadia Healthcare from a "c" rating to a "b-" rating in a research note on Monday, March 4th. TD Cowen lifted their target price on shares of Acadia Healthcare from $86.00 to $101.00 and gave the stock an "outperform" rating in a research note on Friday, March 1st. Barclays started coverage on shares of Acadia Healthcare in a research note on Wednesday, March 6th. They set an "overweight" rating and a $100.00 target price for the company. Finally, Stephens raised shares of Acadia Healthcare from an "equal weight" rating to an "overweight" rating and set a $92.00 target price for the company in a research note on Friday, January 5th. Three analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $94.75.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.